Clinical trial
Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST…
NCT00461929 · University Health Network, Toronto, Other · Terminated
Key facts
| NCT number | NCT00461929 |
|---|---|
| Title | Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib |
| Official title | Are the Secondary Chromosome Abnormalities Seen in Chronic Myeloid Leukemia (CML) Cells Induced to Ph-Chromosome Negativity by Imatinib a Result of Chromosome Instability or a Side Effect of the Therapy - a Study in GIST (Gastrointestinal Stromal Cell Tumors) Patients Treated With Imatinib. |
| Acronym | GIST |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Princess Margaret Hospital, Canada Mount Sinai Hospital, Canada Novartis Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Myeloid Leukemia, Gastrointestinal Stromal Cell Tumors, Chromosome Abnormality |
| Intervention type | Procedure |
| Interventions | bone marrow aspiration |
| Enrollment | 68 |
| Start date | Feb 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Apr 18, 2007 |
| Last update posted | Feb 13, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: